Data Integrity Issues Highlighted In FY 2007 Warning Letters
This article was originally published in The Gold Sheet
Executive Summary
Testing and data integrity issues gained prominence in last year’s warning letters, Atlanta District official says. Meanwhile, FDA inspections begin focusing more overseas.